Bank Of Montreal Revolution Medicines, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$26.56 - $33.55 $741,130 - $936,179	27,904 New	27,904 $899,000
Q3 2022 Nov 10, 2022	SELL	$17.46 - $26.0 $1.54 Million - $2.29 Million	-87,949 Reduced 99.88%	104 $2,000
Q2 2022 Aug 11, 2022	BUY	$14.54 - $27.17 $1.28 Million - $2.39 Million	88,053 New	88,053 $1.68 Million

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.